The company's financial position is characterized by a significant $49.5 million deficit in retained earnings, though recent capital injections have expanded total assets to $48.8 million as of 2026Q3.
| Total Current Assets | 40.49M | 8.56M | 3.7M | 4.9M | 2.58M | 2.94M | 53.71K | 321.87K | 321.87K |
| Cash & Short-Term Investments | 39.42M | 6.96M | 2.81M | 4.05M | 2.11M | 2.86M | 45.42K | 314.83K | 314.83K |
| Cash Only | 39.42M | 6.96M | 2.81M | 4.05M | 2.11M | 2.86M | 45.42K | 36.08K | 36.08K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 278.75K | 278.75K |
| Accounts Receivable | 225.15K | 304.42K | 328.28K | 461.14K | 158.41K | 76.88K | 8.29K | 1.54K | 1.54K |
| Days Sales Outstanding | 514.59 | 480.58 | 355.01 | 1.54K | - | 739.82 | 12.91 | 5.1 | 5.1 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 137.05K | 218.48K | 0 | 0 | 0 | -873 | 0 | 0 |
| Total Non-Current Assets | 8.29M | 4.27M | 3.25M | 2.68M | 639.54K | 92.07K | 134.46K | 300K | 300K |
| Property, Plant & Equipment | 8.29M | 4.27M | 3.25M | 2.68M | 634.62K | 70.84K | 84.96K | 0 | 0 |
| Fixed Asset Turnover | 0.04x | 0.05x | 0.10x | 0.04x | - | 0.54x | 2.76x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 1.37K | 4.92K | 21.23K | 49.5K | 299.53K | 221.91K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 48.78M | 12.83M | 6.96M | 7.58M | 3.22M | 3.03M | 188.17K | 621.87K | 621.87K |
| Asset Turnover | 0.01x | 0.02x | 0.05x | 0.01x | - | 0.01x | 1.25x | 0.18x | 0.18x |
| Asset Growth % | 417.97% | 84.49% | -8.23% | 135.33% | 6.35% | 1509.71% | -69.74% | - | - |
| Total Current Liabilities | 539.13K | 528.66K | 502.3K | 517.29K | 662.16K | 584.38K | 1.02M | 31.3K | 31.3K |
| Accounts Payable | 473.78K | 468.04K | 461.95K | 455.05K | 585.1K | 405.24K | 479.33K | 1.67K | 1.67K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 27.48K | 30.93K | 30.5K | 304.77K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 37.88K | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | -49.38K | 0 | -7.66K | 28.37K | 28.37K |
| Current Ratio | 75.10x | 16.19x | 7.37x | 9.48x | 3.90x | 5.03x | 0.05x | 10.28x | 10.28x |
| Quick Ratio | 75.10x | 16.19x | 7.37x | 9.48x | 3.90x | 5.03x | 0.05x | 10.28x | 10.28x |
| Cash Conversion Cycle | 514.59 | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.92M | 513.38K | 98.23K | 95.73K | 164.58K | 625.82K | 388.02K | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 27.36K | 625.82K | 299.96K | 0 | 0 |
| Capital Lease Obligations | 296.13K | 110.33K | 98.23K | 95.73K | 137.22K | 113.58K | 12.61K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 7.86M | 403.05K | 0 | 0 | 0 | 0 | 75.45K | 0 | 0 |
| Total Liabilities | 8.46M | 1.04M | 600.53K | 613.02K | 826.75K | 1.21M | 1.4M | 31.3K | 31.3K |
| Total Debt | 126.64K | 170.95K | 138.59K | 157.98K | 241.64K | 668.92K | 695.81K | 0 | 0 |
| Net Debt | -39.3M | -6.79M | -2.68M | -3.89M | -1.87M | -2.19M | 650.39K | -36.08K | -36.08K |
| Debt / Equity | 0.00x | 0.01x | 0.02x | 0.02x | 0.10x | 0.37x | - | - | - |
| Debt / EBITDA | -0.01x | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 2.33x | - | - | - | - | - | - | - | - |
| Interest Coverage | -1136.80x | -448.67x | -234.41x | -225.30x | -108.78x | -46.01x | -4.14x | - | - |
| Total Equity | 40.32M | 11.79M | 6.36M | 6.97M | 2.39M | 1.82M | -1.22M | 590.57K | 590.57K |
| Equity Growth % | 338.08% | 85.53% | -8.78% | 190.98% | 31.66% | 249.64% | -305.8% | - | - |
| Book Value per Share | 1.22 | 0.43 | 0.31 | 0.40 | 0.19 | 0.33 | -0.89 | 0.27 | 0.27 |
| Total Shareholders' Equity | 40.32M | 11.79M | 6.36M | 6.97M | 2.39M | 1.82M | -1.22M | 590.57K | 590.57K |
| Common Stock | 77.74M | 38.11M | 22.48M | 15.4M | 6.53M | 3.48M | 91.2K | 838.83K | 838.83K |
| Retained Earnings | -49.46M | -35.04M | -22.9M | -15.46M | -9.6M | -4.52M | -1.31M | -263.26K | -263.26K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 15K | 15K | 15K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital runway exhaustion risk
According to recent financial statements, ADUR's total assets surged to $48.8 million in 2026Q3 from $15.7 million in 2026Q2, a rapid expansion that appears primarily driven by external capital injections rather than organic growth or the accumulation of productive, revenue-generating assets within the firm's core operations.
The sudden increase in the asset base suggests a successful capital raise, which provides a temporary buffer for the company's intensive R&D activities. However, investors should monitor whether this capital can be efficiently converted into commercial-scale technology milestones, as the current trajectory remains heavily dependent on external funding rather than internal cash generation.
As reported in quarterly filings, the company's cash balance reached $39.4 million in 2026Q3, providing a significant liquidity buffer compared to the $9.3 million held in 2026Q2, though this liquidity remains highly sensitive to the company's ongoing, non-recurring project-based funding and high R&D expenditure requirements.
While the current ratio of 75.10 indicates an exceptionally strong short-term liquidity position, this metric is somewhat misleading for a pre-revenue firm in the intensive burn phase. The liquidity is essentially a finite runway that will continue to deplete until the company achieves a self-sustaining commercial model or secures further non-dilutive financing.
Based on the provided balance sheet data, net PPE increased to $8.3 million in 2026Q3 from $5.6 million in 2026Q2, reflecting the company's ongoing investment in physical pilot plant infrastructure necessary to validate its proprietary Hydrochemolytic Technology at a scale beyond laboratory environments.
The concentration of assets in PPE highlights the capital-intensive nature of transitioning from theoretical IP to industrial application. This asset mix suggests that the company is moving toward a more tangible operational footprint, though the ultimate value of these assets remains tied to the successful commercialization of the HCT process.
As indicated by the company's financial records, retained earnings have deepened to a deficit of $49.5 million as of 2026Q3, a trend that underscores the persistent erosion of shareholder equity due to the company's ongoing, high-cost research and development phase and lack of commercial revenue.
The accumulation of these losses suggests that the company is effectively consuming its equity base to fund its technological development. Investors should remain cautious regarding potential future dilution, as the current equity structure may require further capital raises to sustain operations if commercial milestones are not met in the near term.
Quick answers to the most common questions about buying ADUR stock.
As of 2025, Aduro Clean Technologies Inc. (ADUR) had total assets of $12.8M including $8.6M in current assets.
Aduro Clean Technologies Inc. (ADUR) carries total debt of $0.2M, offset by $7.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Aduro Clean Technologies Inc. (ADUR) has total shareholders' equity (book value) of $11.8M ($0.43 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Aduro Clean Technologies Inc. (ADUR) reported a current ratio of 16.19x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.